Regulation & law · 07/10/2005
NIH Seeks Exclusive License for Antiviral Agents Against Poxvirus
The National Institutes of Health is considering granting an exclusive license to practice certain antiviral agents against poxvirus, as described in patent applications filed by N&N Scientific.